BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28

• BioMidwest

  BioRx Introduces National Physical Therapy Program for Patients With Hemophilia

  February 19, 2013

   · 

  1 min read
• Business

  Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion

  February 19, 2013

   · 

  1 min read
• Novo Nordisk Canada Inc. Celebrates 90 Years of Diabetes Innovation

  February 19, 2013

   · 

  4 min read
• Drug Development

  Imprimis Pharmaceuticals Announces Successful Results From Its Pharmacokinetic Study for Its Impracor Topical NSAID

  February 19, 2013

   · 

  4 min read
• The Norovirus Continues to Spread Globally, but Invisible Shield Technology Has a Solution

  February 19, 2013

   · 

  2 min read
• Business

  Baxter International, Inc. Further Expands Halle, Germany Facility to Support BioPharma Solutions’ Cytotoxic Contract Manufacturing Services

  February 19, 2013

   · 

  2 min read
• Business

  WaferGen Biosystems and QIAGEN KK Sign Agreement for Co-Marketing in Japan

  February 19, 2013

   · 

  5 min read
• Drug Development

  Luye Pharma Group Ltd. Completes US Phase II Trial of Cardiovascular TCM

  February 19, 2013

   · 

  1 min read
• Business

  Vermillion to Report Results for Fourth Quarter and Full Year 2012 on Wednesday, February 20, 2013

  February 19, 2013

   · 

  1 min read
• Drug Development

  Intra-Cellular Therapies, Inc. Announces Completion of Phase I Single Rising Dose Trial of First-in-Class Selective Phosphodiesterase 1 (PDE1) Inhibitor and Reports Top-line Safety and Pharmacokinetic Findings

  February 19, 2013

   · 

  3 min read